This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Talk:5-MeO-aMT: Difference between revisions
>Tracer Chemistry, pharmacology |
>$aintPablo m →Legal status: Added United States stating that 5-MeO-aMT is considered Schedule I by the DOJ when intended for human consumption. |
||
| (14 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
{{decree|type=notice|message=This article is in the 'Talk' namespace because it is an unfinished draft. This section is used to host drafts for unpublished articles as well as discussions for published ones. If you'd like to use this area to discuss this draft, please do so in the 'Discussion' section at the very bottom of the page. This notice will be removed once this draft has been approved for publication by an administrator.}} | |||
{{headerpanel|{{Approval}}}} | |||
{{SummarySheet}} | {{SummarySheet}} | ||
{{SubstanceBox/5-MeO-aMT}} | {{SubstanceBox/5-MeO-aMT}} | ||
| Line 12: | Line 14: | ||
==Pharmacology== | ==Pharmacology== | ||
{{pharmacology}} | |||
{{Further|Serotonergic psychedelic}} | {{Further|Serotonergic psychedelic}} | ||
5-MeO-aMT's [[psychedelic]] effects are believed to come from its efficacy at the [[Serotonin#The 5-HT system|5-HT<sub>2A</sub> receptor]] as a [[Agonist#Agonists|partial agonist]]. However, the role of these interactions and how they result in the [[psychedelic]] experience continues to remain elusive. | 5-MeO-aMT's [[psychedelic]] effects are believed to come from its efficacy at the [[Serotonin#The 5-HT system|5-HT<sub>2A</sub> receptor]] as a [[Agonist#Agonists|partial agonist]]. However, the role of these interactions and how they result in the [[psychedelic]] experience continues to remain elusive. | ||
| Line 142: | Line 145: | ||
|} | |} | ||
== | ==Legal status== | ||
{{legalStub}} | {{legalStub}} | ||
*'''United States''': 5-MeO-AMT is unscheduled in the United States. It is possible that it could be considered an analog (of AMT), in which case, sales for human consumption or possession with the intent to ingest could be prosecuted under the Federal Analogue Act. The DEA and the US Department of Justice consider 5-MeO-AMT a controlled substance analogue, making it a Schedule I substance when intended for human consumption.<ref>{{Citation | year=2022 | title=5-MeO-AMT Fast Facts | publisher=US DOJ | url=https://www.justice.gov/archive/ndic/pubs9/9576/index.htm}}</ref> | |||
==See also== | ==See also== | ||
| Line 168: | Line 171: | ||
[[Category:Entactogen]] | [[Category:Entactogen]] | ||
[[Category:Stimulant]] | [[Category:Stimulant]] | ||
[[Category: | [[Category:Articles in talk page]] | ||
[[Category:Proofread]] | [[Category:Proofread]] | ||